Authors call for integrating routine audiometric screening into standard diabetes care
TUESDAY, July 14, 2026 (HealthDay News) — Hearing impairment is a significant, yet underrecognized complication of diabetes, according to a review published online June 23 in Diabetes Metabolism Research and Reviews.
Mehwish Nisar, M.D., from the University of Queensland in Brisbane, Australia, and colleagues conducted a systematic literature review to quantify the prevalence and comparative risk for moderate-to-severe hearing loss in diabetes and prediabetes.
The researchers found that data from 23 studies (5,221 participants) yielded a pooled prevalence of 24 percent for hearing loss among individuals with diabetes. Compared with controls, 11 studies showed patients with diabetes had doubled odds of hearing loss (odds ratio [OR], 2.41; 95 percent confidence interval [CI], 1.62 to 3.60). In younger adults, the risk was significantly elevated (younger than 60 years: OR, 3.03; 95 percent CI, 2.17 to 4.22). However, this risk was not seen in adults aged 60 years and older (OR, 1.52; 95 percent CI, 0.72 to 3.22). Risk was higher with a shorter diabetes duration (<10 years: OR, 2.68; 95 percent CI, 1.61 to 4.47). While there were small-study effects, sensitivity analyses confirmed robustness.
“Despite clear links, hearing loss is not yet systematically integrated into diabetes care protocols,” Nisar said in a statement. “Raising awareness of this hidden complication could help identify hearing problems earlier and improve quality of life for millions of people.”
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage
Voice Disorders Linked to Elevated Risk for Incident Cognitive Decline
Very Low-Carb Diet Shows Greater Cardiometabolic Benefits Than Other Diets
Time-Restricted Eating May Help Patients With Type 1 Diabetes
Food-Based Support Aids Type 2 Diabetes Outcomes
GLP-1 Receptor Agonists Tied to Increased Risk for Alopecia
Hypoglossal Nerve Stimulation May Offer Long-Term Cardiovascular Benefits in OSA
Setmelanotide Beneficial in Acquired Hypothalamic Obesity